Blum Robert I bought CYTK
September 14, 2026 · Form 4 insider transaction
Blum Robert I bought 7,500 shares of Cytokinetics, Incorporated at $10.60 per share, a transaction worth $79.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
$10.60
Total value
$79.5K
InsiderBlum Robert I
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 14, 2026
Filing dateSeptember 15, 2026
Shares owned after385,320
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Acquisition of shares of common stock upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c).